Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients

AIMS: The aims of this study were to develop a combined population pharmacokinetic model for both aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients and to identify to what extent the genetic polymorphisms of cytochrome P450 (CYP) enzymes contribute to the variabili...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, Jung-Ryul, Seo, Hyo-Bum, Cho, Joo-Youn, Kang, Do-Hyung, Kim, Yong Ku, Bahk, Won-Myong, Yu, Kyung-Sang, Shin, Sang-Goo, Kwon, Jun Soo, Jang, In-Jin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2008
Gaiak:
Pharmacokinetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2675764/
https://ncbi.nlm.nih.gov/pubmed/19032724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03223.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak